Predictors of tolerance to chemotherapy in older cancer patients: A prospective pilot study

European Journal of Cancer

Volumn 38, Issue 11, 2002, Pages 1466-1473

  Extermann, M ^a   Chen, H ^a   Cantor, A B ^a   Corcoran, M B ^a   Meyer, J ^a   Grendys, E ^a   Cavanaugh, D ^a   Antonek, S ^a   Camarata, A ^a   Haley, W E ^a   Balducci, L ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Aged; Aged >80 years; Chemotherapy toxicity; Comprehensive geriatric assessment; Predictive factors

Indexed keywords

ANTINEOPLASTIC AGENT; BIRICODAR; CAPECITABINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; MITOXANTRONE; NAVELBINE; PACLITAXEL; PREDNISONE; RITUXIMAB;

AGE; AGED; AGING; ANEMIA; ARTICLE; BODY MASS; CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RISK; CONSTIPATION; CONTROLLED STUDY; DEHYDRATION; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DRUG TOLERANCE; EDEMA; ERYTHROCYTE; FEMALE; FEVER; HEADACHE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; HYPOTENSION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; NEUTROPENIA; PAIN; PILOT STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; THROMBOCYTOPENIA; VERTIGO; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; NEOPLASMS; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 0036317758     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00090-4     Document Type: Article

References (30)

1. First-cycle blood counts and subsequent neutropenia, dose reduction, or delay in early-stage breast cancer therapy
2. Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer
3. Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens
4. Factors that predict chemotherapy-induced myelosuppression in lymphoma patients: Role of the tumor necrosis factor ligand-receptor system
5. A research and service oriented multilevel assessment instrument
6. Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version
7. "Mini Mental State". A practical method for grading the cognitive status of patients for the clinician
8. Mini Nutritional Assessment: a practical assessment tool for grading the nutritional state of elderly patients
9. The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure
10. Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale
11. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
12. Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma
13. CHOP is the standard regimen in patients > or=70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: Results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group
14. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma
15. Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study
16. Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma
17. Gemcitabine in the treatment of refractory Hodgkin's disease: Results of a multicenter phase II study
18. Activity of single-agent gemcitabine as second-line treatment after previous chemotherapy or radiotherapy in advanced non-small-cell lung cancer
19. Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer
20. General guidelines for the management of older patients with cancer. NCCN proceedings
21. Role of red blood cells in pharmacokinetics of chemotherapeutic agents
22. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer
23. Adverse effect of anticonvulsivants on the efficacy of chemotherapy for acute lymphoblastic leukaemia
24. Patterns of care related to age of breast cancer patients
25. Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancer
26. Cancer chemotherapy in the older patient
27. E 1594 - A randomized phase III trial in metastatic non-small cell lung cancer - Outcome of PS 2 patients: An Eastern Cooperative Group trial
28. Nutritional behaviour and quality of life during oncological polychemotherapy: Results of a prospective study on the efficacy of oral nutrition therapy in patients with acute leukemia
29. A predictive model for life-threatening neutropenia and febrile neutropenia after the first course of CHOP chemotherapy in patients with aggressive non-Hodgkin's lymphoma